key: cord-0974406-lzqcvqzh
authors: Fullana, Miquel A.; Littarelli, Sergio A.
title: Covid-19, anxiety, and anxiety-related disorders
date: 2021-05-25
journal: Eur Neuropsychopharmacol
DOI: 10.1016/j.euroneuro.2021.05.008
sha: 0d807a4876d0974dde3ef664c2046990db07614b
doc_id: 974406
cord_uid: lzqcvqzh

nan

Has anxiety increased due to the COVID-19 pandemic? Most will say "absolutely". We say "what do you mean exactly?" and "let's look at the data".

In the mental health research literature, the term "COVID-19 pandemic" has become an umbrella term that involves many different potential threatening situations, from the more individual or local (e.g., death of a loved one) to the more global (e.g., country-wide lockdowns). The fact that this pandemic has affected in some way almost every human on earth, probably combined with how easy it is to collect psychological data online (plus some rush to publish), has made it almost inevitable that the pandemic has been followed by an "infodemic" (Asmundson and Taylor, 2021) .

Hundreds of studies have been published on the psychological effects of the COVID-19 pandemic. Unfortunately, some of these studies have forgotten that good operationalizations and reliable measurements are vital in science. For example, in the COVID-19 literature, terms such as "trauma" or "posttraumatic stress disorder" (PTSD) have been used for situations that do not qualify as such according to current criteria. Then it does not come as a surprise that the prevalence of PTSD associated with COVID-19 has ranged between 5 and 50% (Asmundson and Taylor, 2021) .

Telling if variable increases as a consequence of "something" means that we have assessed the variable before and after the "something", i.e., we need longitudinal prospective designs with a baseline assessment where the "something" has not yet occurred. Very few such studies exist in the COVID-19 mental health literature. A study in a representative sample of the general population in the Netherlands did not find an increase in general anxiety symptoms when the period between November 2018 and March 2019 was compared to the period between November 2019 and March 2020 (van der Velden et al., 2020) .

Focusing on the effects of enforced isolation (i.e., lockdowns), a longitudinal prospective study in the UK did find an increase in general anxiety symptoms after the lockdown, although the high levels of anxiety observed in the early stages of the lockdown declined rapidly, i.e., individuals seemed to adapt quickly to the new circumstances (Fancourt et al., 2021) . Note, however, that in this study the data were collected after the start of the pandemic and that they did not come from a nationally representative sample. Another UK study started after the pandemic onset (April 2020) found that for most people (around 70%) of the general population a trajectory characterized by little-to-no anxiety and PTSD symptoms was the most common trajectory (Shevlin et al., 2021) . Taken together, these three studies suggest that, in the general population, anxiety and PTSD symptoms have not "inevitably" increased due to the pandemic. Of course, when talking about one long stressor like a pandemic, timing matters and one could argue that in the above-mentioned Dutch study the negative psychological effects of the pandemic may have been/will be more evident later. Location also matters: the negative effects of the pandemic may be more obvious in those contexts/populations hard-hit by the virus, be it the elderly (Shan Wong et al., 2020) , healthcare workers (Mortier et al., 2021) , parents -specifically, mothers (see Racine et al., 2021) , or COVID-19 survivors (Taquet et al., 2021) .

If we focus on anxiety-related disorders (including PTSD and obsessive-compulsive disorder, OCD) instead of symptoms, two questions seem especially relevant: 1) Have we seen an increase in new cases?, and 2) What happened to those already diagnosed?

Unfortunately, data to answer these questions is scarce. We have reviewed the literature until April 2021and we are not aware of any study assessing the incidence (new cases) of anxietyrelated disorders before and after the pandemic, therefore we cannot conclude that there has been an increase in new anxiety-related diagnoses associated with the pandemic. As regards the potential increase of anxiety in those who already had an anxiety-related disorder, Pan et al. (2021) did not find evidence of an increase in anxiety or obsessive-compulsive symptoms during the COVID-19 pandemic in patients with lifetime anxiety-related disorders. These data were collected in the first month of lockdownin the Netherlands. As mentioned before, generalizing these findings to other time frames or geographical contexts is not easy.

Clinicians may tell a different story than epidemiologists or researchers. Although for some individuals with anxiety-related disorders the pandemic has led to an increase in general distress, for some it may have meant a decrease in specific anxiety symptoms. For example, strict guidelines on social distancing associated with COVID-19 meant "having to" avoid social contact or staying outside, which has been a relief rather than a hindrance for many (e.g., those with a social anxiety disorder or with agoraphobia). For those people, going back to normality (to "post-COVID life", whatever it means) may be more challenging than coping with the pandemic (see also Vinkers et al., 2021) .

One disorder that has received special attention is OCD, especially contaminationbased OCD. Although we have seen some patients with OCD whose contamination-related symptoms have increased during the pandemic, we have also seen many whose symptoms have not changed at all. Notably, at some point, as clinicians, we had to adapt our criteria of "normality" regarding OCD (what did "cleaning your hands excessively" mean during the first months of the pandemic?). We also had to adjust some treatment strategies: for example, was it ethically acceptable to ask a patient conducting exposure and response prevention to touch a doorknob and not cleaning his/her hands afterward?. Luckily, experienced clinicians offered some guidance on these issues (Sheu et al., 2020) .

To sum up, current data do not confirm the (widely held, in our opinion) belief that anxiety symptoms and disorders have dramatically increased in association/as a result of the COVID-19 pandemic, neither in the general population nor in patients with anxiety-related disorders. However, it may be too early to have detected such potential negative effects, and/or such an increase may be specific to certain contexts or populations. Future studies using longitudinal prospective designs and carefully defined outcomes should shed further light on this issue.

We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author.

Miquel A. Fullana, on behalf of all authors

Garbage in, garbage out: The tenuous state of research on PTSD in the context of the COVID-19 pandemic and infodemic

Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in England: a longitudinal observational study

The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts

Maternal depressive and anxiety symptoms before and during the COVID-19 pandemic in Canada: a longitudinal analysis

COVID-19 and OCD: Potential impact of exposure and response prevention therapy

2021. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Anxiety and depression symptoms, and lack of emotional support among the general population before and during the COVID-19 pandemic. A prospective national study on prevalence and risk factors

Stress resilience during the coronavirus pandemic

Impact of COVID-19 on loneliness, mental health, and health service utilisation: a prospective cohort study of older adults with multimorbidity in primary care